RBR-6mjd8bx招募中2 期
Oral minoxidil 2.5 mg versus 5 mg for the treatment of male Androgenetic Alopecia: a double-blind randomized clinical trial
Faculdade de Medicina de Botucatu0 个研究点开始时间: 2022年8月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 25Y 至 55Y（—）
- 性别
- Male
入选标准
- •male; aged between 25 and 55 years; diagnosis of androgenetic alopecia; classified on the Norwood Hamilton scale as 3V, 4V or 5V; agreeing to participate in the research
排除标准
- •previous treatment for hair loss in the last 4 months; hypertensive patients; patients with heart disease; nephropathy; hepatopathy; patients with pheochromocytoma; patients with other causes of hair loss or scalp dermatoses
研究者
相似试验
尚未招募
不适用
Minoxidil 5 mg oral versus Minoxidil 5% topical solution for Male Pattern Baldness: randomized clinical trialmale androgenetic alopeciaC17.800.329.937.122L64.9RBR-252w9rniversidade Estadual Paulista Julio de Mesquita Filho
尚未招募
Unknown
Minoxidil 5 mg oral versus Minoxidil 5 mg sublingual for treating Male Pattern BaldnessC17.800.329.937Androgenetic alopeciaRBR-7wsgdm8Clinica Sanabria Transplante e Restauração Capilar
招募中
3 期
Comparison of the therapeutic effects of minoxidil solution alone with the combination of minoxidil and flutamide solution in patients with androgenic alopeciaIRCT20200825048515N6Esfahan University of Medical Sciences40
尚未招募
3 期
To see the efficacy of oral minoxidil versus topical minoxidil in male pattern hair loss.CTRI/2024/03/063576not applicable
招募中
3 期
Comparison of the effect of 5% minoxidil and topical epinephrine on the prevention of chemotherapy-induced hair loss in patients with breast cancer compared to the control group (placebo recipients) in 1398-1399Chemotherapy-induced hair loss.IRCT20200205046380N1Shahid Beheshti University of Medical Sciences63